MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with E

Eslicarbazepine

Eslicarbazepine 200mg tablets

No stability information

Stability notes for Eslicarbazepine 200mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Eslicarbazepine 200mg tablets
Arupsan 200mg tablets (Accord-UK Ltd)
Eslicarbazepine 200mg tablets (A A H Pharmaceuticals Ltd)
Eslicarbazepine 200mg tablets (Alliance Healthcare (Distribution) Ltd)
Eslicarbazepine 200mg tablets (Amarox Ltd)
Eslicarbazepine 200mg tablets (Aristo Pharma Ltd)
Eslicarbazepine 200mg tablets (Torrent Pharma (UK) Ltd)
Zebinix 200mg tablets (BIAL Pharma UK Ltd)
Zebinix 200mg tablets (CST Pharma Ltd)

Eslicarbazepine 400mg tablets

No stability information

Stability notes for Eslicarbazepine 400mg tablets

There are no stability notes for this medicine.

Supplier

Eslicarbazepine 400mg tablets (Ascend Laboratories (UK) Ltd)

Eslicarbazepine 600mg tablets

No stability information

Stability notes for Eslicarbazepine 600mg tablets

There are no stability notes for this medicine.

Supplier

Eslicarbazepine 600mg tablets (Ascend Laboratories (UK) Ltd)

Eslicarbazepine 800mg tablets

Compatible

Stability notes for Eslicarbazepine 800mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zebinix 800mg tablets (BIAL Pharma UK Ltd).

Suppliers (10) of Eslicarbazepine 800mg tablets
Arupsan 800mg tablets (Accord-UK Ltd)
Eslicarbazepine 800mg tablets (A A H Pharmaceuticals Ltd)
Eslicarbazepine 800mg tablets (Alliance Healthcare (Distribution) Ltd)
Eslicarbazepine 800mg tablets (Amarox Ltd)
Eslicarbazepine 800mg tablets (Milpharm Ltd)
Eslicarbazepine 800mg tablets (Torrent Pharma (UK) Ltd)
Eslicarbazepine 800mg tablets (Zentiva Pharma UK Ltd)
Zebinix 800mg tablets (BIAL Pharma UK Ltd)
Zebinix 800mg tablets (CST Pharma Ltd)
Zebinix 800mg tablets (Pharmaram Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.